BR0012093A - Composto tricìclico tendo união espiro - Google Patents

Composto tricìclico tendo união espiro

Info

Publication number
BR0012093A
BR0012093A BR0012093-6A BR0012093A BR0012093A BR 0012093 A BR0012093 A BR 0012093A BR 0012093 A BR0012093 A BR 0012093A BR 0012093 A BR0012093 A BR 0012093A
Authority
BR
Brazil
Prior art keywords
spiro union
tricyclic compound
compound
useful
relates
Prior art date
Application number
BR0012093-6A
Other languages
English (en)
Inventor
Hidemitsu Nishida
Fumihiko Saitoh
Kousuke Harada
Ikuya Shiromizu
Original Assignee
Mochida Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Pharm Co Ltd filed Critical Mochida Pharm Co Ltd
Publication of BR0012093A publication Critical patent/BR0012093A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/20—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)
    • G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/96444—Factor X (3.4.21.6)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Prostheses (AREA)
  • External Artificial Organs (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

"COMPOSTO TRICìCLICO TENDO UNIãO ESPIRO". A presente invenção refere-se a compostos tricíclicos que possuem união espiro representados pelo fórmula (I) seguinte ou seus sais que são úteis como uma droga e, em particular, como um inibidor para fator X de coagulação sang³ínea ativada, que podem ser administrados oralmente e que exibem forte ação de anticoagulação. A presente invenção também se refere a um farmacóforo que foi derivado do composto e é útil no projeto molecular do inibidor Fxa.
BR0012093-6A 1999-06-30 2000-06-30 Composto tricìclico tendo união espiro BR0012093A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP22288399 1999-06-30
PCT/JP2000/004374 WO2001002397A1 (fr) 1999-06-30 2000-06-30 Composes tricycliques presentant une jonction spiro

Publications (1)

Publication Number Publication Date
BR0012093A true BR0012093A (pt) 2002-07-16

Family

ID=16789385

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0012093-6A BR0012093A (pt) 1999-06-30 2000-06-30 Composto tricìclico tendo união espiro

Country Status (21)

Country Link
EP (1) EP1191028B1 (pt)
JP (1) JP4890707B2 (pt)
KR (1) KR20020015061A (pt)
CN (1) CN1371375A (pt)
AT (1) ATE281457T1 (pt)
AU (1) AU774397B2 (pt)
BR (1) BR0012093A (pt)
CA (1) CA2380852C (pt)
CZ (1) CZ20014696A3 (pt)
DE (1) DE60015541T2 (pt)
HK (1) HK1049157A1 (pt)
HU (1) HUP0202188A3 (pt)
IL (1) IL147348A0 (pt)
MX (1) MXPA02000003A (pt)
NO (1) NO20016402L (pt)
NZ (1) NZ516363A (pt)
PL (1) PL352862A1 (pt)
SK (1) SK19292001A3 (pt)
TR (1) TR200103853T2 (pt)
WO (1) WO2001002397A1 (pt)
ZA (1) ZA200110558B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030187023A1 (en) * 2000-07-17 2003-10-02 Keiji Kubo Sulfone derivatives, process for their production and use thereof
WO2002053568A1 (fr) * 2000-12-28 2002-07-11 Mochida Pharmaceutical Co., Ltd. Inhibiteurs de la biosynthese du cholesterol contenant comme principe actif des composes spiro tricycliques
CN100513398C (zh) 2002-12-03 2009-07-15 Axys药物公司 作为因子viia抑制剂的2-(2-羟基联苯-3-基)-1h-苯并咪唑-5-甲脒衍生物
TWI396686B (zh) 2004-05-21 2013-05-21 Takeda Pharmaceutical 環狀醯胺衍生物、以及其製品和用法
WO2006006490A1 (ja) * 2004-07-08 2006-01-19 Ono Pharmaceutical Co., Ltd. スピロ化合物
US20090076015A1 (en) 2005-03-31 2009-03-19 Hidemitsu Nishida Tricyclic Spiro Compound Comprising Acyl Group Bound to Nitrogen Atom in the Ring
CA2651420A1 (en) 2006-05-23 2007-11-29 Mochida Pharmaceutical Co., Ltd. Spiro tetracyclic compound
US7739434B2 (en) 2008-01-11 2010-06-15 International Business Machines Corporation Performing a configuration virtual topology change and instruction therefore

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3855147D1 (de) * 1987-07-20 1996-05-02 Duphar Int Res 8,9-Anellierte 1,2,3,4-Tetrahydro-beta-carbolin-Derivate
US5292747A (en) * 1990-08-07 1994-03-08 Hoffman-La Roche Inc. Substituted pyrroles

Also Published As

Publication number Publication date
EP1191028A4 (en) 2002-10-23
AU774397B2 (en) 2004-06-24
EP1191028B1 (en) 2004-11-03
HUP0202188A3 (en) 2004-04-28
TR200103853T2 (tr) 2002-11-21
JP4890707B2 (ja) 2012-03-07
HK1049157A1 (zh) 2003-05-02
IL147348A0 (en) 2002-08-14
WO2001002397A9 (fr) 2001-04-05
HUP0202188A2 (en) 2002-10-28
CN1371375A (zh) 2002-09-25
PL352862A1 (en) 2003-09-08
NO20016402L (no) 2002-02-27
MXPA02000003A (es) 2003-07-21
ZA200110558B (en) 2002-09-12
CA2380852A1 (en) 2001-01-11
NO20016402D0 (no) 2001-12-28
CA2380852C (en) 2009-10-20
NZ516363A (en) 2004-05-28
CZ20014696A3 (cs) 2002-05-15
DE60015541D1 (de) 2004-12-09
KR20020015061A (ko) 2002-02-27
DE60015541T2 (de) 2005-12-08
SK19292001A3 (sk) 2002-06-04
ATE281457T1 (de) 2004-11-15
WO2001002397A1 (fr) 2001-01-11
AU5572000A (en) 2001-01-22
EP1191028A1 (en) 2002-03-27

Similar Documents

Publication Publication Date Title
BR0206580A (pt) Composição farmacêutica tendo tendência reduzida para cristalização de droga
NO20053794L (no) N-(1-benzyl-2-oxo-2-(1-piperazinyl) etyl)-1-piperidinkarboksamid-derivater og relaterte forbindelsers bruk som CGRP-antagonister for behandling av hodepine.
BR0014178A (pt) Derivados de ácido dicarboxìlico com propriedades farmacêuticas
BRPI0608245A2 (pt) compostos; processo para a sua fabricação; composições farmacêuticas; método para o tratamento e/ou prevenção de doenças que estejam associadas à modulação de receptores de sst subtipo 5 e uso dos compostos
BR0116115A (pt) Derivados de carboxamida e seu uso no tratamento de doenças tromboembólicas e tumores
ATE402174T1 (de) Imidazopyridinderivate als kinaseinhibitoren
BRPI0409255A (pt) derivados de ácido 2-(8,9-dioxo-2,6-diazabi-ciclo(5.2.0)non-1(7)-en-2-il)alquil fosfÈnico e seu uso como antagonistas de receptores de d-asparto de -n-metila (nmda)
BR9914451A (pt) Composto de oxazol, processo para sua preparação, composição farmacêutica compreendendo dito composto, uso da composição e métodos de tratamento
BR0113519A (pt) Heterociclos bicìclicos, composições farmacêuticas contendo esses compostos, seu uso e processos para sua preparação
EA200200938A1 (ru) Фармацевтические композиции, содержащие производные азетидина, новые производные азетидина и их получение
BRPI0407591A (pt) inibidores de transcriptase reversa de não-nucleosìdeo
DE60219911D1 (de) Pyrrolidin-2-on derivate als faktor xa inhibitoren
BR0012093A (pt) Composto tricìclico tendo união espiro
BR0210293A (pt) Uma preparação farmacêutica aquosa de cilostazol para utilização parenteral
UY27018A1 (es) Derivados de la pirimidina
BR0315801A (pt) Compostos piridopirimidinona, eu processo de preparação e as composições farmacêuticas que os contêm
NO20050903L (no) Nye piperazinyl-pyrazinonderivater for behandling av 5HT-2A reseptorrelaterte forstyrrelser
BRPI0518560A2 (pt) composto antitrombàtico, composiÇço farmacÊutica, processo para a preparaÇço do composto e uso do composto
BR0306927A (pt) Compostos tricìclicos de 2-pirimidona úteis como inibidores de transcriptase reversa de hiv
BR0015333A (pt) Derivados de isoxazol como inibidores de fosfodiesterase vii
BR0308807A (pt) Compostos tiazol-2-il-imina como inibidores de pde-7
WO2002026732A1 (fr) Derive de benzodiazepine
BRPI0713439A2 (pt) derivados aminados de b-homoandrostanos e b-heteroandrostanos
BR0013306A (pt) Processos úteis na sìntese de compostos antipicornavirais
BR0317693A (pt) Derivados de epotilona

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1962 DE 12/08/2008.